
As India prepares for mass vaccination against Covid once approvals come through, states with more people in the 50-plus age group and with co-morbidities such as diabetes and hypertension are expected to get larger allocations.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3a7EC7G
via
IFTTT
0 comments:
Post a Comment